## Clinical Diagnosis: Disseminated Intravascular Coagulation (DIC) **Key Point:** DIC is a life-threatening syndrome of uncontrolled activation of the coagulation cascade, leading to simultaneous consumption of clotting factors, platelets, and fibrinogen, with paradoxical thrombosis and bleeding. ### DIC Diagnostic Criteria (ISTH Score) | Parameter | Patient Value | Normal Range | Interpretation | |-----------|---------------|--------------|----------------| | Platelet count | 32,000/μL | 150,000–400,000 | Moderate thrombocytopenia (score: 1) | | D-dimer/FDP | 8.5 μg/mL | <0.5 μg/mL | Markedly elevated (score: 3) | | PT prolongation | INR 2.3 | <1.1 | Prolonged (score: 1) | | Fibrinogen | 0.8 g/L | 2–4 g/L | Severely low (score: 1) | | **Total ISTH Score** | **6** | **≥5** | **Consistent with overt DIC** | **High-Yield:** The **ISTH DIC score ≥5** confirms overt DIC with >95% specificity for the diagnosis. ### Pathophysiology of DIC ```mermaid flowchart TD A[Pancreatic cancer tissue factor release]:::outcome --> B[Massive TF-mediated activation of coagulation]:::action B --> C[Thrombin generation in microvasculature]:::action C --> D[Platelet consumption & fibrin deposition]:::action D --> E[Microthrombi form in organs]:::urgent E --> F[Tissue ischemia & multi-organ failure]:::urgent C --> G[Fibrinolysis activated by thrombin-thrombomodulin]:::action G --> H[Plasmin degrades fibrin & factors V, VIII]:::action H --> I[Consumption of fibrinogen & factors]:::outcome I --> J[Thrombocytopenia + coagulopathy]:::outcome J --> K{Bleeding + Thrombosis}:::decision K -->|Bleeding| L[Low platelets, factors, fibrinogen]:::urgent K -->|Thrombosis| M[Microthrombi in lungs, kidneys, brain]:::urgent ``` ### Why This Patient Has DIC **Clinical Pearl:** Pancreatic cancer is one of the **most common malignancies to trigger DIC** because: 1. Pancreatic cancer cells express high levels of **tissue factor (TF)** on their surface 2. TF directly activates Factor VII (extrinsic pathway), bypassing normal regulation 3. Massive thrombin generation overwhelms physiologic anticoagulants (protein C, antithrombin) 4. Widespread intravascular coagulation consumes platelets, fibrinogen, and factors V, VIII, XIII **Mnemonic:** DIC = **D**isseminated **I**ntravascular **C**oagulation — simultaneous **thrombosis** (microthrombi) and **bleeding** (consumption coagulopathy) ### Laboratory Pattern in DIC **Key Point:** DIC produces a characteristic **pentad of lab abnormalities**: 1. **↓ Platelets** — consumed in microthrombi 2. **↓ Fibrinogen** — consumed by thrombin and degraded by plasmin 3. **↑ PT/INR** — consumption of Factors II, V, VII, X 4. **↑ aPTT** — consumption of Factors VIII, IX, XI, XII 5. **↑ D-dimer/FDP** — massive fibrin formation and breakdown **Schistocytes on blood smear** = mechanical fragmentation of RBCs as they traverse microthrombi (microangiopathic hemolytic anemia, MAHA) ### Why Hepatic Dysfunction Is Wrong While advanced pancreatic cancer may involve the liver and cause some hepatic dysfunction, the **pattern of coagulation abnormality differs**: - In liver disease: PT is prolonged early (Factor VII has shortest half-life), but aPTT may be normal initially; fibrinogen is usually normal or low-normal; D-dimer is only mildly elevated - In DIC: PT AND aPTT are both prolonged; fibrinogen is severely low; D-dimer is markedly elevated; schistocytes are present This patient's **markedly elevated D-dimer (8.5) with severe hypofibrinogenemia (0.8) and schistocytes** is diagnostic of DIC, not liver disease. 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.